Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Mesenchymal stem cell and regenerative medicine: regeneration versus immunomodulatory challenges.

Law S, Chaudhuri S.

Am J Stem Cells. 2013 Mar 8;2(1):22-38. Print 2013.

2.

Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Hao L, Sun H, Wang J, Wang T, Wang M, Zou Z.

Int J Hematol. 2012 Jan;95(1):34-46. doi: 10.1007/s12185-011-0991-8. Epub 2011 Dec 20. Review.

PMID:
22183780
3.

Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche.

Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A.

Methods. 2016 Apr 15;99:62-8. doi: 10.1016/j.ymeth.2015.09.016. Epub 2015 Sep 15. Review.

PMID:
26384580
4.

Implications of mesenchymal stem cells in regenerative medicine.

Kariminekoo S, Movassaghpour A, Rahimzadeh A, Talebi M, Shamsasenjan K, Akbarzadeh A.

Artif Cells Nanomed Biotechnol. 2016 May;44(3):749-57. doi: 10.3109/21691401.2015.1129620. Epub 2016 Jan 13. Review.

PMID:
26757594
5.

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

Chamberlain G, Fox J, Ashton B, Middleton J.

Stem Cells. 2007 Nov;25(11):2739-49. Epub 2007 Jul 26. Review.

6.

Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.

Augello A, Kurth TB, De Bari C.

Eur Cell Mater. 2010 Sep 1;20:121-33. Review.

7.

Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.

Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S.

PLoS One. 2013;8(1):e55319. doi: 10.1371/journal.pone.0055319. Epub 2013 Jan 29.

8.

Immunosuppressive properties of mesenchymal stem cells: advances and applications.

De Miguel MP, Fuentes-Julián S, Blázquez-Martínez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F.

Curr Mol Med. 2012 Jun;12(5):574-91. Review.

PMID:
22515979
9.

Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.

Yi T, Song SU.

Arch Pharm Res. 2012 Feb;35(2):213-21. doi: 10.1007/s12272-012-0202-z. Epub 2012 Feb 28. Review.

PMID:
22370776
10.

Stem cells isolated from the human stromal limbus possess immunosuppressant properties.

Garfias Y, Nieves-Hernandez J, Garcia-Mejia M, Estrada-Reyes C, Jimenez-Martinez MC.

Mol Vis. 2012;18:2087-95. Epub 2012 Jul 25.

11.

Treatment of osteochondral defects in the rabbit's knee joint by implantation of allogeneic mesenchymal stem cells in fibrin clots.

Berninger MT, Wexel G, Rummeny EJ, Imhoff AB, Anton M, Henning TD, Vogt S.

J Vis Exp. 2013 May 21;(75):e4423. doi: 10.3791/4423.

12.

Mesenchymal stem cell secretome and regenerative therapy after cancer.

Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD.

Biochimie. 2013 Dec;95(12):2235-45. doi: 10.1016/j.biochi.2013.05.010. Epub 2013 Jun 5. Review.

13.

Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.

Li ZY, Wang CQ, Lu G, Pan XY, Xu KL.

Cell Biochem Biophys. 2014 Sep;70(1):115-22. doi: 10.1007/s12013-014-9866-y.

PMID:
24696072
14.

[Immunoregulatory function of mesenchymal stem cells and application of mesenchymal stem cells in therapy of autoimmune disease].

Kong WX, Jiang XX, Mao N.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Dec;17(6):1605-8. Review. Chinese.

PMID:
20030957
15.

Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Anzalone R, Lo Iacono M, Loria T, Di Stefano A, Giannuzzi P, Farina F, La Rocca G.

Stem Cell Rev. 2011 Jun;7(2):342-63. doi: 10.1007/s12015-010-9196-4. Review.

PMID:
20972649
16.

[Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].

Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D.

Rev Med Interne. 2009 Mar;30(3):287-99. doi: 10.1016/j.revmed.2008.08.019. Epub 2008 Oct 17. Review. French.

PMID:
18930338
17.

Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration.

Takeshita K, Motoike S, Kajiya M, Komatsu N, Takewaki M, Ouhara K, Iwata T, Takeda K, Mizuno N, Fujita T, Kurihara H.

Stem Cell Res Ther. 2017 Apr 26;8(1):101. doi: 10.1186/s13287-017-0550-1.

18.

Mesenchymal stem cell-based gene therapy: A promising therapeutic strategy.

Mohammadian M, Abasi E, Akbarzadeh A.

Artif Cells Nanomed Biotechnol. 2016 Aug;44(5):1206-11. doi: 10.3109/21691401.2015.1029624. Epub 2015 Jul 6. Review.

PMID:
26148175
19.

Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.

Kode JA, Mukherjee S, Joglekar MV, Hardikar AA.

Cytotherapy. 2009;11(4):377-91. doi: 10.1080/14653240903080367. Review.

PMID:
19568970
20.

Mesenchymal stem cells for cardiac cell therapy.

Choi YH, Kurtz A, Stamm C.

Hum Gene Ther. 2011 Jan;22(1):3-17. doi: 10.1089/hum.2010.211. Review.

PMID:
21062128

Supplemental Content

Support Center